Lates News

Roche Pharmaceuticals plans to test whether its late-stage experimental drug can prevent Alzheimer's symptoms in high-risk populations. The company's research will focus on those at risk of cognitive decline. The company hopes to slow the progression of symptoms, or potentially prevent the onset altogether.